Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can better care models keep cancer survivors healthier?

NCT ID NCT04745754

Knowledge-focused Sponsor: Kaiser Permanente Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at two new models of follow-up care for people who have finished treatment for early-stage breast or colorectal cancer. The goal is to see if these models help survivors get the recommended cancer surveillance and preventive care. About 2450 adults from Kaiser Permanente Southern California are taking part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 2,450 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2021

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients: Adult (21+) Kaiser Permanente Southern California members diagnosed and treated for pathologically confirmed first primary early-stage breast (stage 0, I, II) or colorectal (stage I, II) cancer within Kaiser Permanente Southern California. Completed active cancer treatment within the past 6-36 months; active treatment includes cancer-directed surgery, chemotherapy (includes Herceptin (Trastuzumab)), radiation therapy, and ovarian suppression therapy (e.g., Goserelin (Zoladex)). Completed at least one office visit within Kaiser Permanente Southern California medical oncology. At low-risk for cancer recurrence and treatment-related toxicities based on state of disease and treatment modalities. For our Aim 2 survey: Primary language of English or Spanish (although we will assess our Aim 1 participants for recorded preferred spoken language and adjust translations as needed). Ability to complete surveys of patient-reported outcomes. * Physicians: For centers assigned to the embedded primary care physician (PCP) model, PCPs selected to participate must be Board Certified in a relevant primary care specialty; hold a valid and current MD or advanced practitioner license; and be employed by the Southern California Permanente Medical Group. Exclusion criteria: * Patients less than 21 years of age * Patients at high risk for recurrence and treatment-related toxicities based on stage of disease and treatment modalities

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colorectal cancer colorectal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Breast cancer Colorectal cancer

Contacts and locations

Locations

  • Kaiser Permanente Antelope Valley Medical Center Oncology Clinic

    Lancaster, California, 93534, United States

  • Kaiser Permanente Baldwin Park Medical Center Oncology Clinic

    Baldwin Park, California, 91706, United States

  • Kaiser Permanente Downey/Bellflower Medical Center Oncology Clinics

    Downey, California, 90242, United States

  • Kaiser Permanente Fontana Medical Center Oncology Clinic

    Fontana, California, 92335, United States

  • Kaiser Permanente Kern County Medical Facilities Oncology Clinic

    Kern, California, 93306, United States

  • Kaiser Permanente Los Angeles Medical Center Oncology Clinic

    Los Angeles, California, 90027, United States

  • Kaiser Permanente Orange County Anaheim/Irvine Medical Center Oncology Clinics

    Anaheim, California, 92806, United States

  • Kaiser Permanente Panorama City Medical Center Oncology Clinic

    Panorama City, California, 91402, United States

  • Kaiser Permanente Riverside/Palm Springs Medical Center Oncology Clinics

    Riverside, California, 92505, United States

  • Kaiser Permanente San Diego Medical Center Oncology Clinics

    San Diego, California, 92123, United States

  • Kaiser Permanente South Bay Medical Center Oncology Clinic

    Harbor City, California, 90710, United States

  • Kaiser Permanente West Lost Angeles Medical Center Oncology Clinic

    Los Angeles, California, 90034, United States

  • Kaiser Permanente Woodland Hills Medical Center Oncology Clinic

    Woodland Hills, California, 91367, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.